血液加温器市场 - 全球产业规模、份额、趋势、机会、预测：按产品、应用、最终用户、地区和竞争对手划分，2021-2031年

全球血液加温器市场预计将从 2025 年的 17.1 亿美元成长到 2031 年的 23.6 亿美元，复合年增长率为 5.52%。

这些专用医疗设备对于在输注前将静脉输液和血液製品加热至体温至关重要，可显着降低大型手术和创伤治疗期间发生低体温的风险。推动这一市场成长的根本因素包括：复杂外科手术数量的增加、需要大量输血的慢性疾病盛行率的上升，以及基于严格的临床通讯协定对患者进行精准体温管理以提高术后復健率的需求。

根据美国癌症协会预测，2024年美国新增癌症病例将首次超过200万例。这项数据凸显了对外科手术和辅助技术（例如热疗系统）日益增长的需求。然而，由于先进热疗设备及其专用一次性耗材的初始成本和营运成本较高，市场面临严峻的挑战。这些经济限制可能会阻碍小规模医疗机构和预算有限的发展中地区采用这些设备，从而限制其市场渗透率，儘管其临床疗效显着。

市场驱动因素

创伤和急诊病例的增加是推动血液温度监测系统应用的主要动力，尤其是在院前急救和急诊室环境中。严重创伤通常需要大量通讯协定，而快速输注低温液体可能导致“创伤死亡三联征”，即体温过低、凝血功能障碍和酸中毒。因此，急救服务和创伤中心越来越多地采用高流量热疗设备，以在救命治疗期间稳定患者的核心体温。根据美国国家公路交通安全管理局 (NHTSA) 2024 年 4 月的报告显示，2023 年美国约有 40,990 人死于交通事故，这凸显了交通事故创伤带来的沉重负担，这些创伤需要即时复杂的医疗干预，包括液体復苏。

同时，军方和国防部门日益增长的需求正在加速研发和采购专为恶劣环境设计的携带式、坚固耐用的血液热疗解决方案。国防机构正优先推进战场医疗技术的发展，以提高遭受出血性休克的战斗伤者的生存率，这就需要轻便的电池供电设备。这一战略重点得到了大量资金的支持。根据斯德哥尔摩国际和平研究所（SIPRI）2024年4月发布的报告，2023年全球军费开支增长了6.8%，达到创纪录的2.443万亿美元，从而能够扩大战场医疗设备的采购。这项军事措施与更广泛的民用血液製品需求相辅相成。正如美国红十字会在2024年指出的那样，美国每两秒钟就有人需要输血或血小板，这凸显了在频繁输血过程中有效控制体温的普遍必要性。

市场挑战

先进血液疗法设备及其专用一次性耗材的高昂购买和营运成本是全球血液疗法市场扩张的主要障碍。儘管其临床益处已得到充分证实，但采购这些设备的经济负担令采购部门犹豫不决，尤其是在资金有限的小规模区域医院和发展中地区。每次输血都需要一套专用的一次性耗材，加剧了这个问题。一次性资本支出转化为持续的营运成本，迫使许多医疗机构为了维持短期现金流而继续使用过时的系统，从而延缓了升级到更新、更有效率的血液疗法技术。

这种经济压力直接阻碍了市场成长，因为它将目标市场限制在资金雄厚的医疗机构。随着医院营运利润率的下降，辅助手术支援设备的预算拨款往往首当其衝被削减。根据美国医院协会 (AHA) 预测，到 2024 年，医院总支出将增加 5.1%，这成长速度远超整体通膨率，对医疗机构预算造成沉重负担。成本不断上涨的环境限制了投资血液加温设备等专业技术所需的财务柔软性，导致市场渗透率停滞不前，儘管手术量增加，但整体销售额却出现下滑。

市场趋势

智慧连接和物联网功能的融合正在重塑市场格局。随着医疗机构将无缝资料互通性和自动化记录列为优先事项，现代血液加温系统越来越多地采用无线模组。这使得温度资料能够即时传输到电子健康记录 (EHR) 系统，从而确保严格遵守临床文件标准。这种数位化不仅减轻了护理人员的行政负担，而且透过实现对输液参数的持续远端监测，提高了病患安全。欧洲心血管研究所 (ECRI) 于 2024 年 12 月发布的《2025 年安全优先事项》也支持这一趋势，该报告强调了人工智慧医疗技术在临床环境中的重要性。

同时，随着消除交叉感染和简化医院工作流程的迫切需求，市场正经历着向一次性热敏套装的重大转变。医疗机构倾向于采用干热技术，该技术使用无菌的、患者专用的盒式装置和导管，无需在手术间隙进行耗时的消毒程序。这种对高週转率耗材的偏好，在严格遵守感染控制通讯协定的同时，也提高了高容量手术中心的运作效率。这种对耗材主导医疗解决方案的需求，正在推动主要製造商的财务成长。例如，Solventum公司报告称，其2025年8月的总销售额增长了3.9%，其中，受强劲的手术耗材需求驱动，医疗外科业务成为成长的主要动力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血液加温器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（携带式血液/输液加温器，非携带式血液/输液加温器）
  • 按应用领域（外科手术、急诊、新生儿护理、居家医疗等）
  • 依最终用户（医院/诊所、门诊服务机构、国防机构、救援机构）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美血液加温器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲血液加温器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区血液加温器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲血液加温器市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美血液加温器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球血液加温器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Stryker Corporation
• Gentherm Medical, LLC
• Belmont Instrument, LLC
• 3M Company
• ICU Medical, Inc.
• Vyaire Medical, Inc.
• The Surgical Company Holding BV
• Life Warmer Inc.
• Estill Medical Technologies, Inc.
• Smisson-Cartledge Biomedical, LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Blood Warmer Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to USD 2.36 Billion by 2031, advancing at a CAGR of 5.52%. These specialized medical devices are essential for heating intravenous fluids and blood products to body temperature before transfusion, thereby significantly reducing the risk of hypothermia during major surgeries or trauma care. This market growth is fundamentally underpinned by the rising volume of complex surgical procedures and the increasing prevalence of chronic conditions requiring massive transfusions, alongside strict clinical protocols that mandate precise patient temperature management to enhance post-operative recovery rates.

According to the American Cancer Society, the number of new cancer diagnoses in the United States surpassed 2 million for the first time in 2024, a statistic that highlights the escalating need for surgical interventions and supportive technologies such as blood warming systems. However, the market faces a substantial challenge regarding the high acquisition and operational costs linked to advanced warming units and their proprietary disposables. These financial constraints can deter adoption in smaller healthcare facilities or developing regions where budget allocations for auxiliary surgical devices are limited, potentially restricting broader market penetration despite the evident clinical benefits.

Market Driver

The rising incidence of trauma and emergency cases serves as a primary driver for the adoption of blood warming systems, particularly within prehospital and emergency room environments. Severe injuries often necessitate massive transfusion protocols where the rapid administration of cold fluids can trigger the trauma triad of death-comprising hypothermia, coagulopathy, and acidosis-prompting emergency services and trauma centers to integrate high-flow warming devices to stabilize patient core temperatures during critical resuscitation. As reported by the National Highway Traffic Safety Administration in April 2024, an estimated 40,990 individuals died in motor vehicle traffic crashes in the United States in 2023, a figure that underscores the significant burden of vehicular trauma requiring immediate and complex medical intervention involving fluid resuscitation.

Simultaneously, increasing demand from the military and defense sectors is accelerating the development and procurement of portable, ruggedized blood warming solutions tailored for austere environments. Defense organizations are prioritizing advancements in field medical care to improve survival rates for combat casualties suffering from hemorrhagic shock, creating a need for lightweight, battery-operated equipment. This strategic focus is supported by substantial financial commitments; according to the Stockholm International Peace Research Institute's April 2024 report, global military spending rose by 6.8 percent to reach a historic high of $2443 billion in 2023, facilitating increased procurement of field medical gear. This military initiative complements the broader civilian need for blood products, as the American Red Cross noted in 2024 that someone in the United States requires blood or platelets every two seconds, highlighting the universal necessity for effective temperature management during frequent transfusions.

Market Challenge

The significant acquisition and operational costs associated with advanced blood warming units and their proprietary disposables act as a major barrier to the broader expansion of the Global Blood Warmer Market. Although the clinical benefits are well-established, the financial burden of procuring these devices creates hesitation among procurement departments, particularly in smaller community hospitals and developing regions where capital is limited. The requirement for specialized, single-use disposable sets for each transfusion exacerbates this issue by converting a one-time capital expense into a perpetual operational cost, compelling many healthcare facilities to defer upgrading to newer, more efficient warming technologies in favor of retaining legacy systems to preserve short-term cash flow.

This economic pressure directly inhibits market growth by restricting the addressable market to only the most well-funded institutions. When hospitals face shrinking operating margins, budget allocations for auxiliary surgical support devices are often the first to be reduced. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024, a rate that significantly outpaced overall inflation and placed immense strain on facility budgets. This escalating cost environment limits the fiscal flexibility required to invest in specialized technologies like blood warmers, thereby stalling market penetration and reducing the overall volume of unit sales despite the rising volume of surgical procedures.

Market Trends

The integration of Smart Connectivity and IoT Capabilities is reshaping the market as healthcare providers prioritize devices that offer seamless data interoperability and automated record-keeping. Modern blood warming systems are increasingly equipped with wireless modules that allow for the real-time transmission of temperature data directly to electronic health records (EHR), ensuring strict compliance with clinical documentation standards. This digitization reduces administrative burdens on nursing staff and enhances patient safety by enabling continuous remote monitoring of infusion parameters, a trend underscored by ECRI in December 2024, which identified the deployment of AI-enabled health technologies as the top safety focus for 2025, reflecting the critical volume of smart, connected devices entering the clinical environment.

Concurrently, the market is experiencing a decisive shift toward single-use disposable warming sets, driven by the imperative to eliminate cross-contamination and streamline hospital workflows. Healthcare facilities are favoring dry-heat technologies that utilize sterile, patient-specific cassettes and tubing, thereby negating the need for time-consuming sterilization procedures between cases. This preference for high-turnover consumables promotes operational efficiency in high-throughput surgical centers while adhering to rigorous infection prevention protocols. This demand for consumable-driven medical solutions is fueling financial growth for key manufacturers; for instance, Solventum reported a 3.9% increase in total sales in August 2025, with its MedSurg segment cited as a primary contributor to this growth driven by robust demand for surgical supplies.

Key Market Players

• Stryker Corporation
• Gentherm Medical, LLC
• Belmont Instrument, LLC
• 3M Company
• ICU Medical, Inc.
• Vyaire Medical, Inc.
• The Surgical Company Holding B.V.
• Life Warmer Inc.
• Estill Medical Technologies, Inc.
• Smisson-Cartledge Biomedical, LLC

Report Scope

In this report, the Global Blood Warmer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Warmer Market, By Product

• Portable Blood/IV Warmers Device
• Non-portable Blood/IV Warmers

Blood Warmer Market, By Application

• Surgery
• Acute Care
• New Born Care
• Homecare
• Others

Blood Warmer Market, By End User

• Hospitals/Clinic
• Ambulatory Services
• Defense Forces
• Rescue Forces

Blood Warmer Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Warmer Market.

Available Customizations:

Global Blood Warmer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Warmer Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Portable Blood/IV Warmers Device, Non-portable Blood/IV Warmers)
  • 5.2.2. By Application (Surgery, Acute Care, New Born Care, Homecare, Others)
  • 5.2.3. By End User (Hospitals/Clinic, Ambulatory Services, Defense Forces, Rescue Forces)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Blood Warmer Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Warmer Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Warmer Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Warmer Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Blood Warmer Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Warmer Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Warmer Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Warmer Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Warmer Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Warmer Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Warmer Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Warmer Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Warmer Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Warmer Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Warmer Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Warmer Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Warmer Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Warmer Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Warmer Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Warmer Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Blood Warmer Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Warmer Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Warmer Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Warmer Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Warmer Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Gentherm Medical, LLC
• 15.3. Belmont Instrument, LLC
• 15.4. 3M Company
• 15.5. ICU Medical, Inc.
• 15.6. Vyaire Medical, Inc.
• 15.7. The Surgical Company Holding B.V.
• 15.8. Life Warmer Inc.
• 15.9. Estill Medical Technologies, Inc.
• 15.10. Smisson-Cartledge Biomedical, LLC

16. Strategic Recommendations

17. About Us & Disclaimer